Medical Oncology
Chemotherapy Guidelines
The document available on this page is saved
in Adobe Acrobat PDF format  You require Adobe Acrobat (4.x or better) to view. It is sometimes installed with your internet software. To get a FREE new version click on the Adobe logo, Get Acrobat Reader. * You may be required to restart your internet program after installation. |
 |
The Medical Oncology Treatment
Policy Guidelines Booklet is divided into 3 sections.
The first contains general information such as management of toxicities and
information about drugs which require special precautions. This can be applied
to many treatment situations.
The second section contains the chemotherapy regimens currently considered
as “standard” treatments for a variety of disease types and will
be used when patients are not being entered into clinical trials. Tumour types
not listed are those where it is considered that no chemotherapy regimen has
been reported as showing sufficient benefit to be routinely offered to patients.
The final section is a listing of the chemotherapy and supportive care regimens
currently being investigated in clinical trials. Before commencing a patient
on these regimens the full protocol, kept in the wards or with the data managers
or investigators, must be consulted to ensure compliance with eligibility criteria
and to obtain the full treatment details and schedules for evaluation of efficacy
and toxicity. Patients must be informed that the regimen is part of a clinical
trial and informed of the alternative management options. They must give written
informed consent prior to treatment.
These guidelines will be updated regularly to ensure that the latest treatments of proven efficacy are incorporated into standard treatments and to ensure that the listing of active clinical trials remains current.